Fed. Circ. Examines Invalidation Of Sanofi Injector Pen Patent
After hearing both sides of the story, the Federal Circuit is set to decide whether the Patent Trial and Appeal Board applied the wrong legal test when it invalidated a Sanofi-Aventis...To view the full article, register now.
Already a subscriber? Click here to view full article